Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Daily Top 10 COVID-19 papers



  Free Subscription


5 Ann Intern Med
1 Biochem Biophys Res Commun
13 BMJ
2 Cell
2 Epidemiol Infect
3 J Gen Virol
13 J Infect
10 J Infect Dis
7 Lancet
4 Lancet Gastroenterol Hepatol
3 Lancet Glob Health
1 Lancet HIV
12 Lancet Infect Dis
1 Lancet Oncol
7 Lancet Public Health
13 Lancet Respir Med
30 N Engl J Med
11 PLoS One
1 Proc Natl Acad Sci U S A
2 Vaccine

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Ann Intern Med

  1. ZHANG H, Zhou P, Wei Y, Yue H, et al
    Histopathologic Changes and SARS-CoV-2 Immunostaining in the Lung of a Patient With COVID-19.
    Ann Intern Med. 2020 Mar 12. pii: 2763174. doi: 10.7326/M20-0533.

    Coronavirus Disease 2019 (COVID-19): Protecting Hospitals From the Invisible.
    Ann Intern Med. 2020 Mar 11. pii: 2763036. doi: 10.7326/M20-0751.

  3. CHOPRA V, Toner E, Waldhorn R, Washer L, et al
    How Should U.S. Hospitals Prepare for Coronavirus Disease 2019 (COVID-19)?
    Ann Intern Med. 2020 Mar 11. pii: 2763037. doi: 10.7326/M20-0907.

  4. LAUER SA, Grantz KH, Bi Q, Jones FK, et al
    The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application.
    Ann Intern Med. 2020 Mar 10. pii: 2762808. doi: 10.7326/M20-0504.
    PubMed         Abstract available

  5. TUITE AR, Fisman DN
    Reporting, Epidemic Growth, and Reproduction Numbers for the 2019 Novel Coronavirus (2019-nCoV) Epidemic.
    Ann Intern Med. 2020 Feb 5. pii: 2760912. doi: 10.7326/M20-0358.

    Biochem Biophys Res Commun

  6. LI Y, Li H, Zhou L
    EZH2-mediated H3K27me3 inhibits ACE2 expression.
    Biochem Biophys Res Commun. 2020;526:947-952.
    PubMed         Abstract available


  7. TANG W, Cao Z, Han M, Wang Z, et al
    Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial.
    BMJ. 2020;369:m1849.
    PubMed         Abstract available

  8. SCALLY G, Jacobson B, Abbasi K
    The UK's public health response to covid-19.
    BMJ. 2020;369:m1932.

    Covid-19: Questions remain over UK government's PPE guidance.
    BMJ. 2020;369:m1964.

  10. LOH M, Cherrie JW, Aitken RJ
    Decontamination of respirators in the covid-19 pandemic.
    BMJ. 2020;369:m1986.

  11. HOPKINS SA, Lovick R, Polak L, Bowers B, et al
    Reassessing advance care planning in the light of covid-19.
    BMJ. 2020;369:m1927.

  12. ALI A, Zhongren M, Baloch Z
    Covid-19 in Pakistan and potential repercussions for the world: is the infection on the verge of endemicity?
    BMJ. 2020;369:m1909.

  13. PICCININNI M, Rohmann JL, Foresti L, Lurani C, et al
    Use of all cause mortality to quantify the consequences of covid-19 in Nembro, Lombardy: descriptive study.
    BMJ. 2020;369:m1835.
    PubMed         Abstract available

  14. GREEN ST, Cladi L
    Cassandra's curse and covid-19: why do governments listen to businesses over doctors?
    BMJ. 2020;369:m1852.

  15. HIRSCHHORN L, Smith JD, Frisch MF, Binagwaho A, et al
    Integrating implementation science into covid-19 response and recovery.
    BMJ. 2020;369:m1888.

  16. HADI S
    Covid-19: Exposing frontline NHS staff to dangers by asking them to reuse PPE.
    BMJ. 2020;369:m1911.

  17. MEHDI A
    Covid-19: planning a future that focuses on sustainability, health, and social value.
    BMJ. 2020;369:m1919.

  18. MAHEVAS M, Tran VT, Roumier M, Chabrol A, et al
    Clinical efficacy of hydroxychloroquine in patients with covid-19 pneumonia who require oxygen: observational comparative study using routine care data.
    BMJ. 2020;369:m1844.
    PubMed         Abstract available

  19. ALDERWICK H, Dunn P, Dixon J
    England's health policy response to covid-19.
    BMJ. 2020;369:m1937.


  20. OBERFELD B, Achanta A, Carpenter K, Chen P, et al
    SnapShot: COVID-19.
    Cell. 2020;181:954-954.
    PubMed         Abstract available

  21. MONTEIL V, Kwon H, Prado P, Hagelkruys A, et al
    Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2.
    Cell. 2020;181:905-913.
    PubMed         Abstract available

    Epidemiol Infect

  22. MANGIAROTTI S, Peyre M, Zhang Y, Huc M, et al
    Chaos theory applied to the outbreak of COVID-19: an ancillary approach to decision making in pandemic context.
    Epidemiol Infect. 2020;148:e95.
    PubMed         Abstract available

  23. JI M, Yuan L, Shen W, Lv J, et al
    Characteristics of disease progress in patients with coronavirus disease 2019 in Wuhan, China.
    Epidemiol Infect. 2020;148:e94.
    PubMed         Abstract available

    J Gen Virol

  24. EIDEN S, Dijkman R, Zell R, Fuchs J, et al
    Using a mouse-adapted A/HK/01/68 influenza virus to analyse the impact of NS1 evolution in codons 196 and 231 on viral replication and virulence.
    J Gen Virol. 2020 May 14. doi: 10.1099/jgv.0.001422.
    PubMed         Abstract available

  25. MAJID NN, Omar AR, Mariatulqabtiah AR
    Negligible effect of chicken cytokine IL-12 integration into recombinant fowlpox viruses expressing avian influenza virus neuraminidase N1 on host cellular immune responses.
    J Gen Virol. 2020 May 19. doi: 10.1099/jgv.0.001428.
    PubMed         Abstract available

  26. MAO L, Liang P, Li W, Zhang S, et al
    Exosomes promote caprine parainfluenza virus type 3 infection by inhibiting autophagy.
    J Gen Virol. 2020 May 19. doi: 10.1099/jgv.0.001424.
    PubMed         Abstract available

    J Infect

  27. WEN F, Yu H, Guo J, Li Y, et al
    Identification of the hyper-variable genomic hotspot for the novel coronavirus SARS-CoV-2.
    J Infect. 2020 Mar 4. pii: S0163-4453(20)30108.

  28. LEE J, Lee YH, Chang HH, Choi SH, et al
    Comparison of short-term mortality between mechanically ventilated patients with COVID-19 and influenza in a setting of sustainable healthcare system.
    J Infect. 2020 May 8. pii: S0163-4453(20)30278.

  29. HUANG L, Zhang X, Zhang X, Wei Z, et al
    Rapid asymptomatic transmission of COVID-19 during the incubation period demonstrating strong infectivity in a cluster of youngsters aged 16-23 years outside Wuhan and characteristics of young patients with COVID-19: A prospective contact-tracing stud
    J Infect. 2020;80:e1-e13.
    PubMed         Abstract available

  30. FU L, Wang B, Yuan T, Chen X, et al
    Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: A systematic review and meta-analysis.
    J Infect. 2020;80:656-665.
    PubMed         Abstract available

  31. LI H, Xiang X, Ren H, Xu L, et al
    SAA is a biomarker to distinguish the severity and prognosis of Coronavirus Disease 2019 (COVID-19).
    J Infect. 2020 Apr 8. pii: S0163-4453(20)30162.
    PubMed         Abstract available

  32. LI DL, Chen MX
    Critical patients with coronavirus disease 2019: Risk factors and outcome nomogram.
    J Infect. 2020 Apr 6. pii: S0163-4453(20)30153.

  33. WANG L, He W, Yu X, Hu D, et al
    Coronavirus Disease 2019 in elderly patients: characteristics and prognostic factors based on 4-week follow-up.
    J Infect. 2020 Mar 30. pii: S0163-4453(20)30146.
    PubMed         Abstract available

  34. YE Q, Wang B, Mao J
    The pathogenesis and treatment of the `Cytokine Storm' in COVID-19.
    J Infect. 2020;80:607-613.
    PubMed         Abstract available

  35. KWOK KO, Wong V, Wei VWI, Wong SYS, et al
    Novel coronavirus (2019-nCoV) cases in Hong Kong and implications for further spread.
    J Infect. 2020 Feb 21. pii: S0163-4453(20)30084.

  36. YANG P, Liu P, Li D, Zhao D, et al
    Corona Virus Disease 2019, a growing threat to children?
    J Infect. 2020;80:671-693.

  37. LIU K, Chen Y, Lin R, Han K, et al
    Clinical feature of COVID-19 in elderly patients: a comparison with young and middle-aged patients.
    J Infect. 2020 Mar 11. pii: S0163-4453(20)30116.
    PubMed         Abstract available

  38. LEI P, Fan B, Mao J, Wang P, et al
    Comprehensive analysis for diagnosis of novel coronavirus disease (COVID-19) infection.
    J Infect. 2020 Mar 19. pii: S0163-4453(20)30142.

  39. KWOK KO, Lai F, Wei WI, Wong SYS, et al
    Herd immunity - estimating the level required to halt the COVID-19 epidemics in affected countries.
    J Infect. 2020 Mar 21. pii: S0163-4453(20)30154.

    J Infect Dis

  40. SCHWARZ TF, McPhee RA, Launay O, Leroux-Roels G, et al
    Immunogenicity and safety of 3 formulations of a respiratory syncytial virus candidate vaccine in non-pregnant women: a phase II, randomized trial.
    J Infect Dis. 2019 Aug 16. pii: 5550410. doi: 10.1093.
    PubMed         Abstract available

  41. YU P, Zhu J, Zhang Z, Han Y, et al
    A Familial Cluster of Infection Associated With the 2019 Novel Coronavirus Indicating Possible Person-to-Person Transmission During the Incubation Period.
    J Infect Dis. 2020;221:1757-1761.
    PubMed         Abstract available

  42. MUNOZ FM, Swamy GK, Hickman SP, Agrawal S, et al
    Safety and Immunogenicity of a Respiratory Syncytial Virus Fusion (F) Protein Nanoparticle Vaccine in Healthy Third-Trimester Pregnant Women and Their Infants.
    J Infect Dis. 2019 Aug 12. pii: 5546089. doi: 10.1093.
    PubMed         Abstract available

  43. KANEKIYO M, Ellis D, King NP
    New Vaccine Design and Delivery Technologies.
    J Infect Dis. 2019 Jan 31. pii: 5304933. doi: 10.1093.
    PubMed         Abstract available

  44. CUI Y, Tian M, Huang D, Wang X, et al
    A 55-Day-Old Female Infant Infected With 2019 Novel Coronavirus Disease: Presenting With Pneumonia, Liver Injury, and Heart Damage.
    J Infect Dis. 2020;221:1775-1781.
    PubMed         Abstract available

  45. WANG Y, Liu Y, Liu L, Wang X, et al
    Clinical Outcomes in 55 Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Who Were Asymptomatic at Hospital Admission in Shenzhen, China.
    J Infect Dis. 2020;221:1770-1774.
    PubMed         Abstract available

  46. WANG F, Nie J, Wang H, Zhao Q, et al
    Characteristics of Peripheral Lymphocyte Subset Alteration in COVID-19 Pneumonia.
    J Infect Dis. 2020;221:1762-1769.
    PubMed         Abstract available

  47. EYAL N, Lipsitch M, Smith PG
    Human challenge studies to accelerate coronavirus vaccine licensure.
    J Infect Dis. 2020 Mar 31. pii: 5814216. doi: 10.1093.
    PubMed         Abstract available

  48. FUKUYAMA S, Iwatsuki-Horimoto K, Kiso M, Nakajima N, et al
    Pathogenesis of influenza A(H7N9) virus in aged non-human primates.
    J Infect Dis. 2020 May 20. pii: 5841298. doi: 10.1093.
    PubMed         Abstract available

  49. ZHANG N, Zhu L, Zhang Y, Zhou C, et al
    Circulating rather than alveolar extracellular DNA levels predict outcomes in influenza.
    J Infect Dis. 2020 May 10. pii: 5841516. doi: 10.1093.
    PubMed         Abstract available


  50. CURTIS N, Sparrow A, Ghebreyesus TA, Netea MG, et al
    Considering BCG vaccination to reduce the impact of COVID-19.
    Lancet. 2020 Apr 30. pii: S0140-6736(20)31025.

  51. MARMOT M
    Society and the slow burn of inequality.
    Lancet. 2020;395:1413-1414.

  52. PANIZ-MONDOLFI AE, Sordillo EM, Marquez-Colmenarez MC, Delgado-Noguera LA, et al
    The arrival of SARS-CoV-2 in Venezuela.
    Lancet. 2020 May 4. pii: S0140-6736(20)31053.

  53. KASS DA, Duggal P, Cingolani O
    Obesity could shift severe COVID-19 disease to younger ages.
    Lancet. 2020 May 4. pii: S0140-6736(20)31024.

  54. FRASER B
    Chile plans controversial COVID-19 certificates.
    Lancet. 2020;395:1473.

  55. CUADRADO-PAYAN E, Montagud-Marrahi E, Torres-Elorza M, Bodro M, et al
    SARS-CoV-2 and influenza virus co-infection.
    Lancet. 2020;395:e84.

  56. SHIFFMAN J, Shawar YR
    Strengthening accountability of the global health metrics enterprise.
    Lancet. 2020;395:1452-1456.

    Lancet Gastroenterol Hepatol

  57. XIAO Y, Pan H, She Q, Wang F, et al
    Prevention of SARS-CoV-2 infection in patients with decompensated cirrhosis.
    Lancet Gastroenterol Hepatol. 2020 Mar 17. pii: S2468-1253(20)30080.

  58. LODDER W, de Roda Husman AM
    SARS-CoV-2 in wastewater: potential health risk, but also data source.
    Lancet Gastroenterol Hepatol. 2020;5:533-534.

  59. IACUCCI M, Cannatelli R, Labarile N, Mao R, et al
    Endoscopy in inflammatory bowel diseases during the COVID-19 pandemic and post-pandemic period.
    Lancet Gastroenterol Hepatol. 2020 Apr 16. pii: S2468-1253(20)30119.
    PubMed         Abstract available

  60. BANGASH MN, Patel J, Parekh D
    COVID-19 and the liver: little cause for concern.
    Lancet Gastroenterol Hepatol. 2020 Mar 20. pii: S2468-1253(20)30084.

    Lancet Glob Health

  61. GORMLEY M, Aspray TJ, Kelly DA
    COVID-19: mitigating transmission via wastewater plumbing systems.
    Lancet Glob Health. 2020;8:e643.

  62. MITJA O, Clotet B
    Use of antiviral drugs to reduce COVID-19 transmission.
    Lancet Glob Health. 2020 Mar 19. pii: S2214-109X(20)30114.

  63. LAZZERINI M, Putoto G
    COVID-19 in Italy: momentous decisions and many uncertainties.
    Lancet Glob Health. 2020 Mar 18. pii: S2214-109X(20)30110.

    Lancet HIV

    Tuberculosis and HIV responses threatened by COVID-19.
    Lancet HIV. 2020 Apr 8. pii: S2352-3018(20)30109.

    Lancet Infect Dis

  65. XIAO Y, Torok ME
    Taking the right measures to control COVID-19.
    Lancet Infect Dis. 2020 Mar 5. pii: S1473-3099(20)30152.

  66. DONG E, Du H, Gardner L
    An interactive web-based dashboard to track COVID-19 in real time.
    Lancet Infect Dis. 2020 Feb 19. pii: S1473-3099(20)30120.

  67. TO KK, Tsang OT, Leung WS, Tam AR, et al
    Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study.
    Lancet Infect Dis. 2020;20:565-574.
    PubMed         Abstract available

  68. CHEN Y, Li L
    SARS-CoV-2: virus dynamics and host response.
    Lancet Infect Dis. 2020;20:515-516.

  69. TUITE AR, Ng V, Rees E, Fisman D, et al
    Estimation of COVID-19 outbreak size in Italy.
    Lancet Infect Dis. 2020 Mar 19. pii: S1473-3099(20)30227.

  70. KUCHARSKI AJ, Russell TW, Diamond C, Liu Y, et al
    Early dynamics of transmission and control of COVID-19: a mathematical modelling study.
    Lancet Infect Dis. 2020 Mar 11. pii: S1473-3099(20)30144.
    PubMed         Abstract available

  71. WILDER-SMITH A, Chiew CJ, Lee VJ
    Can we contain the COVID-19 outbreak with the same measures as for SARS?
    Lancet Infect Dis. 2020 Mar 5. pii: S1473-3099(20)30129.
    PubMed         Abstract available

  72. YAN G, Lee CK, Lam LTM, Yan B, et al
    Covert COVID-19 and false-positive dengue serology in Singapore.
    Lancet Infect Dis. 2020 Mar 4. pii: S1473-3099(20)30158.

  73. THANH HN, Van TN, Thu HNT, Van BN, et al
    Outbreak investigation for COVID-19 in northern Vietnam.
    Lancet Infect Dis. 2020 Mar 4. pii: S1473-3099(20)30159.

  74. XU B, Kraemer MUG
    Open access epidemiological data from the COVID-19 outbreak.
    Lancet Infect Dis. 2020 Feb 19. pii: S1473-3099(20)30119.

  75. HUANG R, Xia J, Chen Y, Shan C, et al
    A family cluster of SARS-CoV-2 infection involving 11 patients in Nanjing, China.
    Lancet Infect Dis. 2020 Feb 28. pii: S1473-3099(20)30147.

  76. SIMPSON CR, Thomas BD, Challen K, De Angelis D, et al
    The UK hibernated pandemic influenza research portfolio: triggered for COVID-19.
    Lancet Infect Dis. 2020 May 15. pii: S1473-3099(20)30398.

    Lancet Oncol

  77. BURKI TK
    Cancer care in the time of COVID-19.
    Lancet Oncol. 2020;21:628.

    Lancet Public Health

  78. ARMOCIDA B, Formenti B, Ussai S, Palestra F, et al
    The Italian health system and the COVID-19 challenge.
    Lancet Public Health. 2020;5:e253.

  79. AHMED F, Ahmed N, Pissarides C, Stiglitz J, et al
    Why inequality could spread COVID-19.
    Lancet Public Health. 2020;5:e240.

  80. BAYHAM J, Fenichel EP
    Impact of school closures for COVID-19 on the US health-care workforce and net mortality: a modelling study.
    Lancet Public Health. 2020;5:e271-e278.
    PubMed         Abstract available

  81. ARMITAGE R, Nellums LB
    The COVID-19 response must be disability inclusive.
    Lancet Public Health. 2020 Mar 27. pii: S2468-2667(20)30076.

  82. ARMITAGE R, Nellums LB
    COVID-19 and the consequences of isolating the elderly.
    Lancet Public Health. 2020 Mar 19. pii: S2468-2667(20)30061.

  83. LEGIDO-QUIGLEY H, Mateos-Garcia JT, Campos VR, Gea-Sanchez M, et al
    The resilience of the Spanish health system against the COVID-19 pandemic.
    Lancet Public Health. 2020 Mar 18. pii: S2468-2667(20)30060.

  84. PREM K, Liu Y, Russell TW, Kucharski AJ, et al
    The effect of control strategies to reduce social mixing on outcomes of the COVID-19 epidemic in Wuhan, China: a modelling study.
    Lancet Public Health. 2020;5:e261-e270.
    PubMed         Abstract available

    Lancet Respir Med

  85. SINHA IP, Harwood R, Semple MG, Hawcutt DB, et al
    COVID-19 infection in children.
    Lancet Respir Med. 2020 Mar 27. pii: S2213-2600(20)30152.

  86. HALPIN DMG, Faner R, Sibila O, Badia JR, et al
    Do chronic respiratory diseases or their treatment affect the risk of SARS-CoV-2 infection?
    Lancet Respir Med. 2020;8:436-438.

    Reflecting on World Asthma Day in the era of COVID-19.
    Lancet Respir Med. 2020 Apr 23. pii: S2213-2600(20)30184.

  88. FANG L, Karakiulakis G, Roth M
    Antihypertensive drugs and risk of COVID-19? - Authors' reply.
    Lancet Respir Med. 2020 Mar 26. pii: S2213-2600(20)30159.

  89. BROWN JD
    Antihypertensive drugs and risk of COVID-19?
    Lancet Respir Med. 2020 Mar 26. pii: S2213-2600(20)30158.

  90. LO KB, McCullough PA, Rangaswami J
    Antihypertensive drugs and risk of COVID-19?
    Lancet Respir Med. 2020 Mar 26. pii: S2213-2600(20)30156.

  91. YANG X, Yu Y, Xu J, Shu H, et al
    Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study.
    Lancet Respir Med. 2020 Feb 24. pii: S2213-2600(20)30079.
    PubMed         Abstract available

  92. BUONSENSO D, Pata D, Chiaretti A
    COVID-19 outbreak: less stethoscope, more ultrasound.
    Lancet Respir Med. 2020 Mar 20. pii: S2213-2600(20)30120.

  93. MATTHAY MA, Aldrich JM, Gotts JE
    Treatment for severe acute respiratory distress syndrome from COVID-19.
    Lancet Respir Med. 2020 Mar 20. pii: S2213-2600(20)30127.

  94. FENG S, Shen C, Xia N, Song W, et al
    Rational use of face masks in the COVID-19 pandemic.
    Lancet Respir Med. 2020 Mar 20. pii: S2213-2600(20)30134.

  95. RAMANATHAN K, Antognini D, Combes A, Paden M, et al
    Planning and provision of ECMO services for severe ARDS during the COVID-19 pandemic and other outbreaks of emerging infectious diseases.
    Lancet Respir Med. 2020 Mar 20. pii: S2213-2600(20)30121.
    PubMed         Abstract available

  96. CHUA F, Armstrong-James D, Desai SR, Barnett J, et al
    The role of CT in case ascertainment and management of COVID-19 pneumonia in the UK: insights from high-incidence regions.
    Lancet Respir Med. 2020 Mar 25. pii: S2213-2600(20)30132.

  97. TIGNANELLI CJ, Ingraham NE, Sparks MA, Reilkoff R, et al
    Antihypertensive drugs and risk of COVID-19?
    Lancet Respir Med. 2020 Mar 26. pii: S2213-2600(20)30153.

    N Engl J Med

  98. RANNEY ML, Griffeth V, Jha AK
    Critical Supply Shortages - The Need for Ventilators and Personal Protective Equipment during the Covid-19 Pandemic.
    N Engl J Med. 2020 Mar 25. doi: 10.1056/NEJMp2006141.

  99. ZHANG X
    Epidemiology of Covid-19.
    N Engl J Med. 2020;382:1869.

  100. SWERDLOW DL, Finelli L, Lipsitch M
    Epidemiology of Covid-19. Reply.
    N Engl J Med. 2020;382:1869-1870.

  101. ZAVASCKI AP, Falci DR
    Clinical Characteristics of Covid-19 in China.
    N Engl J Med. 2020;382:1859.

  102. CHEN ATC, Coura-Filho GB, Rehder MHH
    Clinical Characteristics of Covid-19 in China.
    N Engl J Med. 2020;382:1860.

  103. ROLF JD
    Clinical Characteristics of Covid-19 in China.
    N Engl J Med. 2020;382:1860.

  104. CAO B, Wang Y, Wen D, Liu W, et al
    A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19.
    N Engl J Med. 2020 Mar 18. doi: 10.1056/NEJMoa2001282.
    PubMed         Abstract available

  105. BADEN LR, Rubin EJ
    Covid-19 - The Search for Effective Therapy.
    N Engl J Med. 2020 Mar 18. doi: 10.1056/NEJMe2005477.

  106. ROSE C
    Am I Part of the Cure or Am I Part of the Disease? Keeping Coronavirus Out When a Doctor Comes Home.
    N Engl J Med. 2020;382:1684-1685.

    Facing Covid-19 in Italy - Ethics, Logistics, and Therapeutics on the Epidemic's Front Line.
    N Engl J Med. 2020 Mar 18. doi: 10.1056/NEJMp2005492.

  108. JONES DS
    History in a Crisis - Lessons for Covid-19.
    N Engl J Med. 2020 Mar 12. doi: 10.1056/NEJMp2004361.

  109. HOLLANDER JE, Carr BG
    Virtually Perfect? Telemedicine for Covid-19.
    N Engl J Med. 2020 Mar 11. doi: 10.1056/NEJMp2003539.

  110. GUAN WJ, Ni ZY, Hu Y, Liang WH, et al
    Clinical Characteristics of Coronavirus Disease 2019 in China.
    N Engl J Med. 2020 Feb 28. doi: 10.1056/NEJMoa2002032.
    PubMed         Abstract available

  111. GATES B
    Responding to Covid-19 - A Once-in-a-Century Pandemic?
    N Engl J Med. 2020 Feb 28. doi: 10.1056/NEJMp2003762.

  112. HENRY BM, Vikse J
    Clinical Characteristics of Covid-19 in China.
    N Engl J Med. 2020;382:1860-1861.

  113. GUAN WJ, Zhong NS
    Clinical Characteristics of Covid-19 in China. Reply.
    N Engl J Med. 2020;382:1861-1862.

  114. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Finding Reliable Information about Covid-19.
    N Engl J Med. 2020;382:e81.

  115. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Studying Potential Covid-19 Therapies.
    N Engl J Med. 2020;382:e72.

  116. OXLEY TJ, Mocco J, Majidi S, Kellner CP, et al
    Large-Vessel Stroke as a Presenting Feature of Covid-19 in the Young.
    N Engl J Med. 2020 Apr 28. doi: 10.1056/NEJMc2009787.

  117. PRAMESH CS, Badwe RA
    Cancer Management in India during Covid-19.
    N Engl J Med. 2020 Apr 28. doi: 10.1056/NEJMc2011595.

  118. PETERS AW, Chawla KS, Turnbull ZA
    Transforming ORs into ICUs.
    N Engl J Med. 2020;382:e52.

  119. HAUG C
    French Pandemic Resistance.
    N Engl J Med. 2020;382:e51.

  120. LEUNG GM, Cowling BJ, Wu JT
    From a Sprint to a Marathon in Hong Kong.
    N Engl J Med. 2020;382:e45.

  121. JUDSON SD, van Doremalen N, Munster VJ
    Stability and Viability of SARS-CoV-2. Reply.
    N Engl J Med. 2020;382:1965-1966.

  122. SINGER AJ, Morley EJ, Henry MC
    Staying Ahead of the Wave.
    N Engl J Med. 2020;382:e44.

  123. RUBENS JH, Karakousis PC, Jain SK
    Stability and Viability of SARS-CoV-2.
    N Engl J Med. 2020;382:1962-1963.

  124. SCHWARTZ KL, Kim J, Garber G
    Stability and Viability of SARS-CoV-2.
    N Engl J Med. 2020;382:1963.

  125. LESHO E, Laguio-Vila M, Walsh E
    Stability and Viability of SARS-CoV-2.
    N Engl J Med. 2020;382:1963-1964.

  126. HELMERS A
    Stability and Viability of SARS-CoV-2.
    N Engl J Med. 2020;382:1964.

  127. PETTI S
    Stability and Viability of SARS-CoV-2.
    N Engl J Med. 2020;382:1964-1965.

    PLoS One

  128. KENMOE S, Kengne-Nde C, Modiyinji AF, La Rosa G, et al
    Comparison of health care resource utilization among preterm and term infants hospitalized with Human Respiratory Syncytial Virus infections: A systematic review and meta-analysis of retrospective cohort studies.
    PLoS One. 2020;15:e0229357.
    PubMed         Abstract available

  129. GLINGE C, Engstrom T, Midgley SE, Tanck MWT, et al
    Seasonality of ventricular fibrillation at first myocardial infarction and association with viral exposure.
    PLoS One. 2020;15:e0226936.
    PubMed         Abstract available

  130. VERMA V, Vishwakarma RK, Verma A, Nath DC, et al
    Time-to-Death approach in revealing Chronicity and Severity of COVID-19 across the World.
    PLoS One. 2020;15:e0233074.
    PubMed         Abstract available

  131. LIM W, Zhang P
    Herd immunity and a vaccination game: An experimental study.
    PLoS One. 2020;15:e0232652.
    PubMed         Abstract available

  132. WANG H, Xia Q, Xiong Z, Li Z, et al
    The psychological distress and coping styles in the early stages of the 2019 coronavirus disease (COVID-19) epidemic in the general mainland Chinese population: A web-based survey.
    PLoS One. 2020;15:e0233410.
    PubMed         Abstract available

  133. GAO W, Sanna M, Tsai MK, Wen CP, et al
    Geo-temporal distribution of 1,688 Chinese healthcare workers infected with COVID-19 in severe conditions-A secondary data analysis.
    PLoS One. 2020;15:e0233255.
    PubMed         Abstract available

  134. ZHOU Y, He Y, Yang H, Yu H, et al
    Development and validation a nomogram for predicting the risk of severe COVID-19: A multi-center study in Sichuan, China.
    PLoS One. 2020;15:e0233328.
    PubMed         Abstract available

  135. CHANGOLKAR S, Rewley J, Balachandran M, Rareshide CAL, et al
    Phenotyping physician practice patterns and associations with response to a nudge in the electronic health record for influenza vaccination: A quasi-experimental study.
    PLoS One. 2020;15:e0232895.
    PubMed         Abstract available

  136. MURAYAMA T, Shimizu N, Fujita S, Wakamiya S, et al
    Robust two-stage influenza prediction model considering regular and irregular trends.
    PLoS One. 2020;15:e0233126.
    PubMed         Abstract available

  137. CREPEY P, Redondo E, Diez-Domingo J, Ortiz de Lejarazu R, et al
    From trivalent to quadrivalent influenza vaccines: Public health and economic burden for different immunization strategies in Spain.
    PLoS One. 2020;15:e0233526.
    PubMed         Abstract available

  138. MORBEY RA, Charlett A, Lake I, Mapstone J, et al
    Can syndromic surveillance help forecast winter hospital bed pressures in England?
    PLoS One. 2020;15:e0228804.
    PubMed         Abstract available

    Proc Natl Acad Sci U S A

  139. GATTO M, Bertuzzo E, Mari L, Miccoli S, et al
    Spread and dynamics of the COVID-19 epidemic in Italy: Effects of emergency containment measures.
    Proc Natl Acad Sci U S A. 2020;117:10484-10491.
    PubMed         Abstract available


  140. LIAO Q, Ng TWY, Cowling BJ
    What influenza vaccination programmes are preferred by healthcare personnel? A discrete choice experiment.
    Vaccine. 2020 May 7. pii: S0264-410X(20)30630.
    PubMed         Abstract available

  141. KOPSIDAS I, Tsopela GC, Maroudi-Manta S, Kourkouni E, et al
    Increasing healthcare workers' uptake of seasonal influenza vaccination in a tertiary-care pediatric hospital in Greece with a low-cost, tailor-made, multifaceted strategy.
    Vaccine. 2020 May 16. pii: S0264-410X(20)30639.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.